福泰瑞控股

最新新闻

• 评级变动
  TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)
  TipRanks · 2026/7/30
• 评级变动
  A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $22 to $26
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• UBS Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/9/3
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/8/4
• 评级变动
  Truist Financial Remains a Buy on Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/7/30
• 评级变动
  Barclays Keeps Their Hold Rating on Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/7/30
• Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 评级变动
  Citi Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  William Blair Maintains Fortrea Holdings(FTRE.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• UBS Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/7/31
• Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)
  TipRanks · 2026/9/10
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)
  TipRanks · 2026/8/17
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
  TipRanks · 2026/9/2
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/9/3

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。